PCV21- COST-EFFECTIVENESS ANALYSIS OF ABCIXIMAB, EPTIFIBATIDE, AND TIROFIBAN IN PATIENTS WITH CORONARY SYNDROMES
Sep 1, 2001, 00:00
10.1046/j.1524-4733.2001.40202-95.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71254-2/fulltext
Title :
PCV21- COST-EFFECTIVENESS ANALYSIS OF ABCIXIMAB, EPTIFIBATIDE, AND TIROFIBAN IN PATIENTS WITH CORONARY SYNDROMES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71254-2&doi=10.1046/j.1524-4733.2001.40202-95.x
First page :
Section Title :
Open access? :
No
Section Order :
146